Lv3
330 积分 2024-05-21 加入
99mTc-FAPI-46 Scintigraphy and Radioligand Therapy With 177Lu-FAPI-2286 in Locally Advanced Epithelioid Sarcoma
4天前
已完结
Dual-tracer PET/CT and cocktail therapy with [177Lu]Lu-FAP2286 and [177Lu]Lu-DOTATATE in G3 Neuroendocrine Tumors (NET)
4天前
已完结
Development of Dar3A Chelator and Construction of FAP-Targeted PET Probe as Proof of Concept and for First-in-Human Evaluation
4天前
已完结
Preparation of clinical-scale 177Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling, and freeze-dried kit formulation
1个月前
已完结
A scalable protocol for the radiosynthesis of clinical grade lutetium-177-labeled theranostic agents
1个月前
已完结
Preparation of 177Lu-PSMA-617 in Hospital Radiopharmacy: Convenient Formulation of a Clinical Dose Using a Single-Vial Freeze-Dried PSMA-617 Kit Developed In-House
1个月前
已完结
Freeze-dried multi-dose kits for the fast preparation of 177Lu-Tyr3-octreotide and 177Lu-PSMA(inhibitor) under GMP conditions
1个月前
已完结
Formulation of patient dose of [177Lu]Lu-Trastuzumab using in-house developed freeze-dried kit: A path forward for clinical translation
1个月前
已完结
Preparation of DOTA-TATE and DOTA-NOC freeze-dried kits for formulation of patient doses of 177Lu-labeled agents and their comparison for peptide receptor radionuclide therapy application
1个月前
已完结
Single vial kit formulation of DOTATATE for preparation of 177Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy
1个月前
已完结
皖公网安备34019202002308